Cardiology Journal Articles

• When Does Too Much Energy Become a Danger to the Heart? A new study provides insights into the underlying myocardial energetic processes in normal weight and obese patients with dilated cardiomyopathy.
  European Heart Journal, March 29, 2022
• Using a Smartwatch ECG to Detect SCA-associated Abnormalities Is a smartwatch-derived single-lead ECG recording feasible for identifying electrocardiographic abnormalities associated with sudden cardiac arrest in young adults?
  Europace, March 29, 2022
• Interventions for Frailty Among Older Adults With CVD Review the various definitions of frailty, how frailty can be measured, and interventions to prevent, reverse, or slow the progression of frailty in patients with cardiovascular disease.
  Journal of the American College of Cardiology, March 25, 2022
• Combination Lipid-lowering Therapy in Very High-risk Patients In this commentary, the authors make the case for treating all very high- and extremely high-risk patients with combination lipid-lowering therapy as the basic standard of care.
  European Heart Journal, March 23, 2022
• RNA-targeted Therapeutics in Preventive Cardiology Might RNA-targeted therapeutics aimed at reducing apoB-containing lipoproteins provide an entirely new strategy to prevent atherosclerotic cardiovascular diseases?
  European Heart Journal, March 21, 2022
• Endovascular Treatment for Posterior Circulation Stroke Controversy remains regarding the benefits of endovascular treatment for posterior circulation stroke. This study examined outcomes of patients with PCS treated with EVT in clinical practice.
  Stroke, March 21, 2022
• Interaction of iPhone 12 With Cardiac IEDs An array of magnets in the iPhone 12 has been reported to cause interference with implantable cardioverter-defibrillator and pacemakers.
  Europace, March 15, 2022
• E-Cigarettes and Cardiopulmonary Health This review summarizes what we currently know about the impact of e-cigarettes and vaping on cardiopulmonary health, but there are many unanswered questions.
  Circulation, March 14, 2022
• Vascular Repair and Regeneration in Cardiometabolic Diseases This review presents novel data indicating that intervention using SGLT2 inhibition or gastric bypass can restore cell-mediated vascular repair mechanisms in patients with cardiometabolic disease.
  European Heart Journal, March 14, 2022
• GI Injury by Aspirin or Clopidogrel Monotherapy vs. DAPT A new study explores the mechanisms of mucosal injury and GI bleeding with differing antiplatelet regimens in patients undergoing PCI.
  Journal of the American College of Cardiology, March 11, 2022
• The Year in Cardiovascular Medicine 2021 Review some of the most important recent developments in the field of digital medicine as they relate to cardiovascular medicine, including advances in AI, wearable devices, and imaging tools.
  European Heart Journal, March 09, 2022
• How to Live to 100 Before Developing Coronary Artery Disease In this commentary, Dr. Eugene Braunwald proposes a radical approach to delaying the onset of clinical manifestations of arteriosclerotic cardiovascular disease.
  European Heart Journal, March 07, 2022
• Triggers of Stroke: Anger, Emotional Upset, Physical Exertion A recent study sheds new light on physical and emotional stress as triggers for stroke
  European Heart Journal, March 02, 2022
• Remote Monitoring and Outcomes in HF Patients With an ICD In patients with implantable cardioverter-defibrillators, how are clinical outcomes impacted by partly substituting remote patient monitoring for in-person visits?
  Europace, March 01, 2022
• Colchicine in Cardiovascular Disease: In-Depth Review Colchicine is a safe and well-tolerated anti-inflammatory agent. Explore its mechanisms of action and potential utility in cardiovascular disease in this paper.
  Circulation, February 28, 2022
• The Untapped Potential of Reproductive History in CVD Why is it that women who have had a pregnancy loss have a significantly higher risk of developing cardiovascular disease later in life? A new study examines this complex association.
  European Heart Journal, February 28, 2022
• Coronary Atherosclerotic Plaque Regression This review focuses on novel treatment strategies that may induce atherosclerotic plaque regression, highlighting imaging modalities that can assess changes in plaque volumes and composition.
  Journal of the American College of Cardiology, February 25, 2022
• Intracranial Hemorrhage in the TST Trial This analysis of the TST (Treat Stroke to Target) trial focuses on the possible impact of LDL-lowering statin therapy on risk of incident intracranial hemorrhage.
  Stroke, February 24, 2022
• First and Recurrent Events in the ISCHEMIA Trial A new analysis of the ISCHEMIA trial underscores the complex pathophysiology of ischemic heart disease and the difficulty in attempting to assess outcomes in these patients.
  European Heart Journal, February 23, 2022
• Subcutaneous ICD: The Impedance of Air What was the cause of the sudden battery depletion in this patient with a subcutaneous implantable cardioverter-defibrillator?
  Europace, February 22, 2022